SRTS — Sensus Healthcare Inc

Sensus Healthcare Inc (SRTS) is a medical devices company listed on NASDAQ. It is led by Joseph C. Sardano, based in 851 Broken Sound Parkway NW, Boca Raton, FL, United States, 33487, with about 54 employees. Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Latest reported SRTS revenue for 2025-09-30 was $6.9M. Net income was -$943.0K. Revenue was down 5.9% from 2025-06-30 to 2025-09-30. SRTS currently screens at market cap $76.6M and trailing P/E 42.4.

Use this SRTS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SRTS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SRTS SEC filings page. Lician reads the product cache first so this HTML stays unique to Sensus Healthcare Inc even when a live quote feed is slow.